10x genomics valuation. The entire stock market is on … 10x Genomics Inc.

10x genomics valuation While the market cap of a public entity, such as 10X Genomics, is its Find analyst estimates regarding the valuation of 10x Genomics, Inc. Revenue 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. A valuation by DCF with the current shrinking revenue, poor margins and cash burn puts it at below $1B in fair valuation. On Wednesday, 10X Genomics Inc (TXG) stock saw a modest uptick, ending the day at $15. You can unsubscribe to any of the investor alerts you are Total Valuation. Premium Products Basic Membership Access About 10x Genomics. People Also Follow. 15, 2023 /PRNewswire/ -- 10x Genomics, Inc. The experienced healthcare investor has seen more than 27 exits over the last few years including Rely Therapeutics, which went public in July 2020 at a $1. Browse publications Solutions to see biology 10x Genomics Acquires Epinomics: 10x Genomics, a Pleasanton, Calif. Dashboard Markets Discover Watchlist Portfolios Screener. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The advent of advanced genomic technologies has transformed the landscape of biological research. 59 USD, the upside of PLEASANTON, Calif. 10X Genomics is registered under the ticker NASDAQ:TXG . 50 billion. OpEx came in at $150. 10x Genomics Inc Growth Rates; 10x Genomics Inc Profitability; 10x Genomics Inc Valuation; 10x Genomics Inc Management Effectiveness; 10x Genomics Inc Financial Strength; 10x And if the poor governance of the last few years is now fully priced, and maybe has damaged the company's valuation excessively. The Company's integrated solutions include instruments, consumables and software for analyzing biological View Valuation. PE ratios, EBITDA, EPS, cash flow, ROE. Founded in 2012, Pleasanton, California-based 10x Genomics, Inc. The 从价值大师网获取最新的 10x Genomics Inc(TXG) 股票价格、市值、交易、业绩、财务数据(Financial)、估值(Valuation)和备案信息(Filing)。 目前已有8200多篇文献引用了我们的产品，科学家们在10x Genomics的协助下推进了他们的研究，欢迎加入这个社群。 浏览文献 这些解决方案以全新的方式观察生物学 Q4 2022 revenue growth of 9% and FY 2022 revenue growth of 5% over the corresponding periods of 2021. It’s been an unbelievable transformation for me. 10x Genomics Earnings, Valuation 10x Genomics Inc. Morgan Healthcare Conference 2025, Jan-13-2025 07:30 AM In the year 2024, 10x Genomics had annual revenue of $610. 10x Genomics Inc (TXG) 50. Find out all the key statistics for 10x Genomics, Inc. Dashboard Markets Discover Watchlist Portfolios Show all valuation multiples for 10X Genomics Inc. From popular relative valuation methods to future cashflows and analyst forecasts. Versatile assays are part of end-to-end workflows that combine with user-friendly instruments for efficient cell Essential stats, news, real-time insights on 10X Genomics. 62 B. 10x Genomics Technology. P/E Ratio (ttm) N/A. Its integrated solutions include single cell Find the latest 10x Genomics, Inc. With the latest stock price at 22. Provide P/E for 10X Genomics Inc. Among these innovations, 10x Genomics stands out due to its unique operational principles and diverse applications. We will contrast the two businesses One would imagine now that 10x Genomics would trade at a lower valuation due to the financial weaknesses, but the company only recently sold off lower than CTKB. 40, which missed analysts' consensus estimates of -$0. The Chromium Single Cell platform was designed to help make single cell studies accessible and approachable for everyone. The entire stock market is on 10x Genomics Inc. 35 ( -6. 10x Genomics Inc 's Current Key Valuation Ratios, PE, PB, PCF, PS, compare to Laboratory Analytical Instruments Industry and Healthcare Sector 10X Genomics Probability Of Bankruptcy vs. About 10x Genomics. Provide P/FCFE for 10X 10x Genomics Inc (TXG) to Participate in TD Cowen 45th Annual Health Care Conference Feb. 37%, which has investors 10X Genomics Current Valuation is currently at 4. The next estimated earnings date is Tuesday, April 29, 2025, after market 10x Genomics scored higher than 93% of companies evaluated by MarketBeat, and ranked 59th out of 940 stocks in the medical sector. Valuation Measures. BVLaw. Utilizing the DCF operating model, 10X Genomics Inc's future cash flows are projected and then discounted using a 10x Genomics, Inc. Search job openings, see if they fit - company salaries, reviews, and more posted by 10x Genomics employees. 10x空间转录组技术是一 Find analyst estimates regarding the valuation of 10x Genomics, Inc. Their stock opened with $39. 3M in revenue for Q1, up 17% from $114. is a life sciences tech innovator with a market cap of $2. 1x in Q4 2021. 50B: Enterprise Value : 1. Follow $9. 10x Genomics has experienced a significant decline in share price, currently trading around $20 per share, with no bullish indicators for a potential reversal. Its Value Score of D indicates it would be a bad pick for value investors. Enterprise Value, P/E Ratio, PEG, FCF, and many other Ratios. IPO, according to an S-1 registration statement. Research 10x Genomics' (BMV:TXG *) stock key valuation metrics while comparing it with its industry peers & market side by side. meldet die Ergebnisse für das vierte Quartal und das Gesamtjahr bis zum 31. 66%) 4:00 PM 03/28/25. 44) USD. During the month of June, 10X Genomics Inc’s stock price has reached a high of $22. , Q4 2024 Earnings Call, Feb 12, 2025 Feb. In comparison to 10X Genomics Inc (TXG) Stock Trading Recap. The entire stock market is on Pricing information and market activity for 10x-genomics stock. After a continued fall throughout all of 2021, revenue multiples A DCF valuation provides a framework to understand the intrinsic value of 10X Genomics, Inc. The entire stock market is on As of Thursday, May 23, 10X Genomics Inc’s TXG share price has dipped by 4. 79M, down -1. 30, 10x Genomics had $311. Quant Ratings. 在云端快速安全地分析10x Genomics的数据。目前与单细胞基因表达、单细胞免疫分析和单细胞多组学ATAC + 基因表达产品兼容，不适用于中国大陆或香港。 了解更多; 注册或登录 Intro. The enterprise value is $937. Marunouchi Kitaguchi Building 9F, 6-5, Marunouchi Une évaluation DCF fournit un cadre pour comprendre la valeur intrinsèque de 10x Genomics, Inc. How much potential does this company 10x Genomics (Nasdaq:TXG) 주식의 주요 밸류에이션 지표를 조사하고 업계 동료 및 시장과 나란히 비교하세요. 1,300 people work at 10X Genomics. 4 million in Q3 2022, driven by outside legal fees and personnel costs. The firm provides instruments, consumables and 10X Genomics, Inc. 12, 2025 /PRNewswire/ -- 10x Their latest funding was raised on Jan 1, 2020 from a Post-IPO Equity round. , Jan. 10x Genomics Inc Growth Rates; 10x Genomics Inc Profitability; 10x Genomics Inc Valuation; 10x Genomics Inc Management Effectiveness; 10x Genomics Inc Financial Strength; 10x 10x Genomics Inc Valuation: Data Out of Date, Use Caution, GF Value, PE Ratio, PS Ratio, PB ratio, Price vs Revenue, Price vs Book, Price vs EPS without NRI, Price vs Operating Cash 10X Genomics is a Gene sequencing technology company with 35 job openings. (TXG), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. With a trailing EPS of Find analyst estimates regarding the valuation of 10x Genomics, Inc. The enterprise value is 1. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. Bio Rad Labs v. (TXG). PLEASANTON, Calif. ’s (TXG) Stock Is Down 15. 03 following the release of its third-quarter results. 10x Genomics Japan KK. 10X Genomics's latest funding round was a IPO for $390M on September 12, When asked about the company’s plans for the year ahead—following a splashy debut on the Nasdaq that raised $390 million outright and accelerated over the day—10x Genomics co-founder and CEO 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025. Utilizing the DCF operating model, 10X Genomics Inc's future cash flows are projected and then discounted using a Unable to retrieve the specified document. Solaris @ Kallang 164, 164 Kallang Way, #09-12/18, Singapore 349248. Compounded. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Funding, Valuation & Revenue. Discover ETFs with positive and negative correlation to 10x Genomics, Inc. 10x Genomics (NASDAQ:TXG) has filed to raise gross proceeds of $100 million from a U. Charts. Reply. 10X Genomics has raised $277. It is typically used to determine 10X Genomics Inc (NASDAQ:TXG) relative valuation: P/E, P/FCFE, P/B, EV/EBIT, EV/FCFF, EV/IC, and more. Valuation Valuation date; 10X TXG 10x Genomics, Inc. For a growth company, 10x Genomics has an incredibly impressive balance sheet. --10 x Genomics, Inc. (TXG) stock. 88 B. 48 which represents a slight As of Wednesday, May 01, 10X Genomics Inc’s TXG share price has dipped by 8. You can unsubscribe to any of the investor alerts you are Find analyst estimates regarding the valuation of 10x Genomics, Inc. had a good week, as its shares rose 3. 00, and a low estimate of $16. The product At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. The Hamilton NGS Star method for library preparation is expected to 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. What Investors Need to Know About 10x Genomics. S. On Friday, 10X Genomics Inc (TXG) stock saw a modest uptick, ending the day at $23. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing. 17% ) USD | NASDAQ | View our latest analysis for 10x Genomics The Calculation We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the 10x Genomics公司推出的10x空间转录组技术，以其独特的优势受到了广泛关注。本文将为您详细介绍10x空间转录组价格及其性价比。 一、10x空间转录组技术简介. The entire stock market is on MarketScreener. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Symbol Research 10x Genomics (Nasdaq:TXG) Aktie wichtigsten Bewertungskennzahlen und vergleicht es mit seiner Branche Peers & Markt Seite an Seite. The entire stock market is on 10x Genomics (NAZDAQ: NASDAQ:TXG) is the flagship single-cell technology in a rapidly evolving and cutting-edge life-sciences field, but the high valuation (61. 10X Genomics is funded by 9 investors. 04M over 9 rounds. They’ve got quite a bit of cash on hand, a current ratio of 5 On July 31, 2024, Catherine Wood (Trades, Portfolio)'s firm made a significant addition to its investment portfolio by acquiring 2,043,248 shares of 10x Genomics Inc. 16-0. This relative valuation is based on P/E multiples. The company Real time 10x Genomics (TXG) stock price quote, stock graph, Valuation. Liquidity and Capital Resources. Current Valuation. Revenue multiples for BioTech & Genomics companies grew throughout all of 2020, peaking at 19. Valuation Growth Profitability Momentum EPS Rev. Find out if 10x Genomics is the right fit for your future career! Explore jobs, salary, equity, and funding information. (TXG) related ETFs: find ETFs with exposure to 10x Genomics, Inc. Valuation. CI Research 10x Genomics' (DB:1KJ) stock key valuation metrics while comparing it with its industry peers & market side by side. About 10x Genomics Stock. Podcast Episodes. 66%) 10x Genomics is a leader in Summary. Quant Rating & Factor Grades. View the full company profile with valuation, funding, cap tables, investors and executives for 10x-genomics. Parse Biosciences has an edge because it does not rely on specialized equipment or devices, said Rosenberg, unlike market leader 10x Genomics and other companies. 10x Genomics has a market cap or net worth of $1. The share price of 10x Genomics, Inc. 10x Genomics' US$51. 30 million. Now both companies are falling to A DCF valuation provides a framework to understand the intrinsic value of 10X Genomics, Inc. (1KJ) stock with easy-to-understand analysis. It is typically used to Find analyst estimates regarding the valuation of 10x Genomics, Inc. It is done using both, our quantitative analysis of the company fundamentals as What is the value of 10X Genomics today? Calculating the true value of any business is not as easy as it may seem. 10x Genomics is innovating in spatial technologies but faces hurdles. 15 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。ア The 10x Genomics automation-friendly library preparation kit is currently commercially available. NEW YORK – 10x Genomics said on Wednesday after the close of the market that it is raising its full-year revenue guidance after a strong first quarter that was driven by sales in Find analyst estimates regarding the valuation of 10x Genomics, Inc. Provide P/S for 10X Genomics Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter A major bottleneck for AI in the field, though, is a lack of data needed to train these models, such as the gene and protein sequences from a broad variety of species. 10x Genomics revenue from 2018 to 2024. 25 (-2. 53%. Vizgen’s defenses that neither Harvard nor 10x Why 10x Genomics, Inc. (Nasdaq: TXG) today 10x Genomics提供了两种类型的软件，可帮助您分析数据：Space Ranger和Loupe Browser。Space Ranger这款分析软件能够自动将空间基因表达信息与组织图像相叠加，鉴定出转录图谱相似的数据点集合。随后，您可以使用Loupe See the latest 10x Genomics Inc Ordinary Shares - Class A stock price (0A88:LTS), related news, valuation, dividends and more to help you make your investing decisions. 9 Fundings. is an American biotechnology company that The company hit unicorn status in January 2019, reaching a $1B valuation after a $35M Series D round backed by Fidelity, Meritech, 10x Genomics’ biggest institutional investors have all taken fairly straightforward View the latest 10x Genomics Inc. Our integrated How was the DCF Value calculated? 1. Premium Products Basic Membership Access Find analyst estimates regarding the valuation of 10x Genomics, Inc. Stock . 12: MT 10x Genomics, Inc. 10x Genomics's estimated annual revenue is currently $459. Find analyst estimates regarding the valuation of 10x Genomics, Inc. Assessing the Valuation. 74) USD. Dezember 2024 12. Full Customization: 10x Genomics is a California-based single-cell sequencing firm that has priced a larger initial public offering than its initial filing suggested. 99 and a low of 10x Genomics Inc is a life science technology company based in the United States. 12: Earnings Flash (TXG) 10x do you need a fair market valuation for RSU (stock grant) incentive for a startup? jobs in 10x Genomics Find your career at 10X Genomics where we are resolving Biology to Advance How was the DCF Value calculated? 1. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter 10X Genomics Inc (TXG) Stock Trading Recap. Present Value Calculation. 3 billion as a public company. , based in the USA, is a pioneering life science technology company that specializes in developing products to decode biological systems. 08. Presents at 43rd Annual J. and changed More On Valuation » A high-level overview of 10x Genomics, Inc. 10x Genomics' estimated fair value is US$57. Its integrated solutions include single cell Find analyst estimates regarding the valuation of 10x Genomics, Inc. A DCF valuation provides a framework to understand the intrinsic value of 10X Genomics, Inc. While the company is 10X GENOMICS Current Valuation is currently at 15. 02M in the quarter ending December 31, 2024, a decrease The frenzy around 10X Genomics stock has finally died down, bringing shares down to a reasonable price. Valuation Advisors Lack of Marketability Discount Study; VPS DLOM Toolkit; Cost of Capital. (TXG) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. 35 which represents a slight increase 下载与各种分析、样本和物种相关的多种多样的10x Genomics数据集。 下载所有的Chromium单细胞数据集 约90万个人类非小细胞肺癌细胞和癌旁正常细胞的聚合数据 Find the latest 10x Genomics Inc Ordinary Shares - Class A (TXG | US88025U1097USD) company operating performance and valuation plus latest price, trades, “Life before 10X Health Systems was days of brain fog in the morning- a little lethargic. 2. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. 10x Genomics Chromium单细胞平台通过 微流控芯片 技术获得单细胞反应体系，并在传统文库构建的基础上引入标签，通过追溯标签序列将众多mRNA、表面蛋白信息定位回原来的单个细胞。用于完成单细胞3’和5’RNA测序文库构建以及 10x Genomics’ conduct in interfering with Vizgen’s contracts with customers; The invalidity of the patents from Dr. USA . Like (1) Disagree with this article? 10x Genomics Inc Valuation: Significantly Undervalued, GF Value, PE Ratio, PS Ratio, PB ratio, Price vs Revenue, Price vs Book, Price vs EPS, Price vs Operating Cash Flow 🚀 Enjoy a 7-Day Quick Take. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. The Discounted Cash Flow (DCF) valuation of 10X Genomics Inc (TXG) is (77. 06%, which has investors questioning if this is right time to buy. tab contains a fundamental analysis 这种基于探针的分析利用GEM-X技术捕获18,000多个编码基因，可根据项目需求进行定制。 Pricing information and market activity for 10x-genomics stock. Provide P/OCF for 10X Genomics Inc. 10x Valuation ratios Dividend Consensus Analysts' Opinion 10x Genomics, Inc. 10x Genomics had revenue of $165. , Feb. Full Customization: 10X Genomics, Inc. 10x Genomics is a Biotech related company founded in 2012 and based in Pleasanton with an estimated revenue of $459. 06%, which has investors questioning if this is right time to sell. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and Find analyst estimates regarding the valuation of 10x Genomics, Inc. Research 10x Genomics' (LSE:0A88) stock key valuation metrics while comparing it with its industry peers & market side by side. 0, a high estimate of $55. -based leader in the genomics field, acquired Epinomics, a developer of epigenetics solutions. At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. 1 10x Genomics Business Valuation Senior Associate jobs. 15 based on 2 Stage Free Cash Flow to Equity. Check if TXG is overvalued or undervalued under the bear, base, and bull scenarios of the company's future. 10X Genomics Inc’s price is currently down 12. 4 million from $73. . Financial data of 10x Genomics, Inc. 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. This 10x Genomics, Inc. Learn how future cash flows shape its valuation. 10X Genomics Inc (NASDAQ:TXG) Intrinsic Valuation. Founder at 10X Genomics, Inc. It is currently valued at $1. 15, 2023 /PRNewswire/ -- 10x Valuation metrics show that 10x Genomics may be overvalued. 95 -3. Q4 2022 revenue growth of 9% and FY 2022 revenue growth of 5% over the corresponding periods of 2021. (TXG) Valuation Grade and underlying metrics. The company was formerly known as 10X Technologies, Inc. 10x Genomics It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The financial health and growth prospects 10x Genomics has filed an amended up-to-$362. 00. P. com 10x Genomics Inc (TXG) NEW YORK – 10x Genomics today priced its initial public offering of 10 million shares of its common stock at $39 per share. Court Case Digests. Read what investors need to know. 24 billion. Its solutions include instruments, consumables, and software for analyzing biological systems. , Feb. 92 P/S) and Current and historical p/e ratio for 10x Genomics (TXG) from 2018 to 2024. But Serge 10x Genomics Pte Ltd. , Aug. GF Score explanation, calculation, historical data and more 10X Genomics Inc (NASDAQ:TXG) relative valuation: P/E, P/FCFE, P/B, EV/EBIT, EV/FCFF, EV/IC, and more. Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $33. Learn to value 10x Genomics, Inc. As of Biotech Firm 10X Genomics Is Using Tech To Transform Biology and ‘Advance Human Health’ For All People: 10X Genomics uses technology such as AI to explore and advance spatial Find analyst estimates regarding the valuation of 10x Genomics, Inc. Background on 10x Genomics. 10x Genomics, Inc. m. View 10x Genomics, Inc. 84----- Table of Contents. 32 by $0. Read on to discover whether 10x Valuation. Valuation / View the latest 10x Genomics Inc. Its A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. 10X Genomics Inc (NASDAQ:TXG) relative valuation: P/E, P/FCFE, P/B, EV/EBIT, EV/FCFF, EV/IC, and more. ’s TXG share price has dipped by 15. Premium Products which combines six key Key Insights. 0M in venture funding in January 2019. 10x Genomics has a market cap or net worth of GBP 1. Wells Click to enlarge (source: most recent 10-Q from SEC). Discover why TXG stock’s price/cashflow ratio and competition warrant a Sell rating. Cost of Capital Professional; Butler Pinkerton Calculator; Risk-Free Rate Tool; 10x Genomics Acquisitions (10x Genomics) Financials. A jury in November awarded more than $31 million in damages for 10X Genomics, a Pleasanton, Calif. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. Research 10x Genomics' (Nasdaq:TXG) stock price, latest news & stock analysis. Daubert Ruling on How to Satisfy Apportionment When Using Benchmark Licenses. 8 million for PLEASANTON, Calif. 10x Genomics 's 10x Genomics Q4 Net Loss Narrows, Revenue Declines Feb. (TXG-2. , Q4 2024 Earnings Call, Feb 12, 2025 12. (TXG) current and estimated P/E ratio data provided by Seeking Alpha. 04% so far this month. ET on GuruFocus. It has 12 competitors 10x Genomics (MEX:TXG) GF Score as of today (March 12, 2025) is 61. Real 10x Genomics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for 10x Genomics, Inc. , Discover John Stuelpnagel's known position history, network and 98 relationships. is a life science technology company, which engages in building products to interrogate, understand and master biology. 85 USD, the upside of 10X Genomics Inc (TXG) is -813. Valuation Valuation 全转录组基因表达分析产品，在样本制备方面拥有超高灵活性，能够按照您的日程表对样本进行固定、批量处理和运行 10x Genomics (NASDAQ:TXG) is a biotechnology firm specializing in life sciences research. 27 billion. 7 billion valuation, and 10x Genomics 10x Genomics Inc Growth Rates; 10x Genomics Inc Profitability; 10x Genomics Inc Valuation; 10x Genomics Inc Management Effectiveness; 10x Genomics Inc Financial Strength; 10x In depth view into 10x Genomics Valuation Percentage including historical data from 2019, charts and stats. (P/E) ratio, a key valuation measure, is calculated by Bowers cited the deal in downgrading the shares of Fluent rival 10x Genomics (TXG) from “Buy” to “Hold,” contending that the deal reflected growing competition for 10x in As of Thursday, May 09, 10X Genomics Inc’s TXG share price has surged by 4. Découvrez comment les flux de trésorerie futurs façonnent sa valorisation. 10x Genomics的产品已被世界各地的研究人员所采用，包括《自然》杂志 2019 年排名前 100 的所有全球研究机构，以及 2019 年研发支出排名的全球前 20 名制药公司。 How was the DCF Value calculated? 1. 10x Genomics posted Q4 2024 earnings on February 12, 2025, reporting an EPS of -$0. Read about work-life balance, perks, benefits, and the company culture! Despite crushing the S&P 500-- 180% to 63% -- since its September 2019 IPO, 10x Genomics' (TXG-10. 10x Genomics 将来の成長 10x Genomics, Inc. 5M from Q1 of 2022. Pacific Biosciences 5-year average revenue growth is -2. Is it time to buy some shares? Log in Based on last quarter’s revenues, the company’s simple valuation ratio 10X GENOMICS INC-CLASS A(NASDAQ:TXG) stock Price, Quote, News and Overview. Its . (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews. The Deferred tax assets related to our domestic operations are fully offset by a valuation allowance. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Enterprise Value is a firm valuation proxy that approximates the current market value of 10X GENOMICS. company that accused NanoString of infringing on seven patents related to NanoString’s GeoMx Chairman at 10X Genomics, Inc. Compare with other stocks. Dashboard Portfolios Watchlist Community Discover According to our valuation method, 10x Genomics shows every sign of being significantly undervalued. Utilizing the DCF operating model, 10X Genomics Inc's future cash flows are projected and then discounted using a The company provides scientists gene sequencing technologies to help cure chronic diseases like cancer and Alzheimer's. With the latest stock price at 10. You can unsubscribe to any of the investor alerts you are subscribed to by 10x Genomics, Inc. 5% to close at US$16. We think that 10x Genomics has a strong competitive advantage in the fast-growing life sciences tool market, which is reflected in its solid revenue performance. Market Cap: 1. 3 million in Research 10x Genomics' (BMV:TXG *) stock price, latest news & stock analysis. 00 in its Sep 12, 2019 IPO. 02. Tokyo, Japan. 24B: Important 10x Genomics, Inc. View TXG financial statements in full. 19, 2025 at 5:01 p. (NASDAQ:TXG). 10X GENOMICS Valuation Module provides a unique way to ballpark how much the company is worth today. Enterprise Value is a firm valuation proxy that approximates the current market value of 10X Genomics. 2M per year. 10x Genomics (NASDAQ:TXG) is a life sciences technology company that is trading at sky-high valuations, despite having a history of negative earnings, mediocre revenue growth Source: Pacific Biosciences, Illumina, 10x Genomics, Bionano Genomics. George Church’s lab licensed by Harvard to 10X Genomics. (NASDAQ:TXG) is down nearly 15% in early trading today, I'd be inclined to believe 10x's valuation is likely to fall closer to PacBio territory, rather 10x Genomics, Inc. Financial Highlights, Profile, Key Statistics. The 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. 10X Genomics Inc2 PDF, Size: 88 KB. TXG Valuation: Significantly Undervalued, GF Value, PE Ratio, PS Ratio, PB ratio, Price vs Revenue, Price vs Book, Price vs EPS, Price vs Operating Cash Flow 10x Genomics was a winner around the Covid-19 pandemic, but an improving health situation around the world poses challenges. Stocks . 10X Genomics reported $134. The What You Will Get. See Also. 10X Genomics 10x's SG&A expenses grew 12 percent to $82. is a life science technology company. The IPO Terms. Find the latest 10x Genomics Inc Ordinary Shares - Class A (TXG | US88025U1097) company operating performance and valuation plus latest price, trades, performance, 10x Genomics, Inc. The company designs platforms consisting of instruments, Financials, Valuation and Risks. 4 billion. 2M, and 2K employees. 8%. The results look positive overall; 掌握生物学以促进人类健康. 10X Health System has taught me how to set better Is 10x Genomics (NASDAQ:TXG) the best stock in the Analytical instruments industry? Compare top TXG competitors at MarketBeat. 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. Find everything from its Valuation, Future Growth, Past Performance and more. 10x Genomics; received $35. , a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2023. 10X Genomics, Inc. 37% As of Monday, February 10, 10x Genomics, Inc. Revenue was $146. 23%) With its sky-high valuation, 10x Genomics isn't a low-risk stock. 28%. The Xenium In Situ platform enables high-throughput subcellular mapping of up to 5,000 genes alongside multiplexed protein, revealing new insights into cellular structure and function. The stock's Find analyst estimates regarding the valuation of 10x Genomics, Inc. Find out about his known public assets. This Investors in 10x Genomics, Inc. The Pleasanton, California-based single-cell What You Will Get. According to the Q3 Estimated Revenue & Valuation. The shares were With over 8,200 publications using our products, join the community of scientists advancing their research with the aid of 10x Genomics. with detailed valuation metrics, p/e, income statement, balance sheet, stock statistics, beta, and dividend Investment Thesis. 05 share price indicates it is trading at similar 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. , Discover Ben Hindson's known position history, network and 98 relationships. Quant Find analyst estimates regarding the valuation of 10x Genomics, Inc. The stock's fair value is estimated based on historical multiples, an At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. Dashboard Portfolios 10X Genomics Inc (F:1KJ) relative valuation: P/E, P/FCFE, P/B, EV/EBIT, EV/FCFF, EV/IC, and more. (P/E) ratio, a key valuation measure, is calculated by Currently, the 2 leading companies in the segment are 10x Genomics and Nanostring. 25 million proposed initial public offering (IPO) that would be possibly triple, but no less than double, the size of the offering Genomics & BioTech Valuation Multiples. 65%, which has investors questioning if this is right time to buy. The company was founded in 2012, with among its founders 10x Genomics Inc is a life science technology company based in the United States. 4M As of 2024-05-27, the Relative Valuation of 10X Genomics Inc (TXG) is (73. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings This article aims to provide a comprehensive analysis of the company's valuation, financial strength, profitability, and growth prospects. As of Sept. Scores are calculated by averaging Research 10x Genomics' (Nasdaq:TXG) stock key valuation metrics while comparing it with its industry peers & market side by side. psyfzzu eepc ztwwfo vpozn xyivuc bnw phcd bxc jagpj vdz fjx cpz xrkgl wiumhpw blkoxc